ArticleCancers2018

Better Progression-Free Survival in Elderly Patients with Stage IV Lung Adenocarcinoma Harboring Uncommon Epidermal Growth Factor Receptor Mutations Treated with the First-line Tyrosine Kinase Inhibitors.

Ming-Ju Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.